Klöckner Pentaplast announces $25M investment in capacity expansion in North America
Klöckner Pentaplast’s Pharma & Medical Device Division (kp PMD) recently announced that it will add to its global production capacity in North America.
“Our significant expansion plans reflect our dedication to servicing customers’ needs now, and in the future,” says Tracey Peacock, president of kp PMD, and part of the company group based in Montabaur, Germany. “The additional coating and laminating capability suitable for the production of Pentapharm and Pentamed packaging films will service the North American pharmaceutical and medical device industry. We are excited to support the growing high barrier product segments by investing in best in class coating and laminating capabilities, enabling new performance levels in barrier protection.”
kp PMD is investing $25M over the next few years in technology and processes to ensure they deliver innovative, functional and safe products for customers. This investment in North America complements earlier announcements by kp this year, highlighting their capacity expansions in Switzerland and Brazil. kp plans for the new capability in North America to be operational in 2020.